The intrarenal renin-angiotensin system and diabetic nephropathy

Trends in Endocrinology and Metabolism

Volumn 14, Issue 6, 2003, Pages 274-281

  Carey, Robert M ^a   Siragy, Helmy M ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; PEPTIDE HORMONE; PROTEIN; STREPTOZOCIN;

DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE COURSE; DOWN REGULATION; HEMODYNAMICS; HORMONAL REGULATION; INSULIN RESISTANCE; KIDNEY FUNCTION; PARACRINE SIGNALING; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 0043068157     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(03)00111-5     Document Type: Review

References (82)

1. Cooper, M.E. (1998) Pathogenesis, prevention and treatment of diabetic nephropathy. Lancet 352, 213-219
2. Selby, J.V. et al. (2002) The natural history and epidemiology of diabetic nephropathy: implications for prevention and control. JAMA 263, 1954-1960
3. Jandeleit-Dahn, K. et al. (2002) Hypertension and diabetes. Curr. Opin. Nephrol. Hypertens. 11, 221-228
4. Sharmak, K. et al. (1999) Captopril-induced reduction of serum levels of transforming growth factor-β1 correlates with long-term renoprotection in insulin-dependent diabetic patients. Am. J. Kidney Dis. 34, 818-823
5. ACE Inhibition in Diabetic Nephropathy Trialists Group, (2001) Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin converting enzyme inhibitors? A metaanalysis of individual patients' data. Ann. Intern. Med. 134, 370-379
6. Chan, J.C. et al. (2000) Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertension type 2 diabetic patients. Kidney Int. 57, 590-600
7. Gerstein, H.C. et al. (2000) Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 355, 253-269
8. Brenner, B.M. et al. (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes mellitus and nephropathy. N. Engl. J. Med. 345, 861-869
9. Lewis, E.J. et al. (2001) Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N. Engl. J. Med. 345, 851-860
10. Parving, H-H. et al. (2001) The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N. Engl. J. Med. 345, 870-878
11. Andersen, S. et al. (2000) Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. Kidney Int. 57, 601-606
12. Lewis, E.J. (2002) The role of angiotensin II receptor blockers in preventing the progression of renal disease in patients with type 2 diabetes. Am. J. Hypertens. 15, 123S-128S
13. Navar, L.G. et al. (1996) Paracrine regulation of the renal microcirculation. Physiol. Rev. 76, 425-536
14. Robrwasser, A. et al. (1999) Elements of a paracrine tubular renin-angiotensin system along the entire nephron. Hypertension 34, 1265-1274
15. Henrich, W.L. et al. (1996) Renin regulation in cultured proximal tubule cells. Hypertension 27, 1337-1340
16. Nishiyama, A. et al. (2002) Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats. Hypertension 39, 129-134
17. Kobori, H. et al. (2001) Enhancement of angiotensinogen expression in angiotensin II-dependent hypertension. Hypertension 37, 1329-1335
18. Berry, C. et al. (2001) Angiotensin receptors: signaling, vascular pathophysiology and interactions with ceramide. Am. J. Physiol. Heart Circ. Physiol. 281, H2337-H2365
19. 2 receptor subtypes in the rat kidney. Am. J. Physiol. 277, F437-F446
20. Bouby, N. et al. (1997) Expression of type 1 angiotensin II receptor subtypes and angiotensin II-induced calcium mobilization along the rat nephron. J. Am. Soc. Nephrol. 8, 1658-1667
21. 2) receptor protein in the rat kidney. Hypertension 30, 1238-1246
22. Quan, A. and Baum, M. (1996) Endogenous production of ANG II modulates rat proximal tubule transport. J. Clin. Invest. 97, 2878-2882
23. Wang, T. et al. (1996) Effects of angiotensin II on electrolyte transport in the early and late distal tubule in the rat kidney. Am. J. Physiol. 271, F143-F149
24. Nguyen, G. et al. (1996) Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor 1 antigen. Kidney Int. 50, 1897-1903
25. Nguyen, G. et al. (1998) Evidence of a renin receptor on human mesangial cells: effects on PAI 1 and cGMP. Nephrologie 19, 411-416
26. Nguyen, G. et al. (2002) Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J. Clin. Invest. 109, 1417-1427
27. Erdos, E.G. et al. (2001) Kinins, receptors, kininases and inhibitors. Where did they lead us? Biol. Chem. 382, 43-47
28. Cole, J.M. et al. (2002) Mice lacking endothelial angiotensin converting enzyme have normal blood pressure. Circ. Res. 90, 87-92
29. Cole, J.M. et al. (2003) Mice lacking endothelial ACE. Normal blood pressure with elevated angiotensin II. Hypertension 41, 313-321
30. Tipnis, S.R. et al. (2000) A human homolog of angiotensin converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 275, 33238-33243
31. Donoghue, M. et al. (2000) A novel angiotensin-converting enzyme-related carboxypeptidase (ACE 2) converts angiotensin I to angiotensin (1-9). Circ. Res. 87, 1-9
32. Crackower, M.A. et al. (2002) Angiotensin converting enzyme 2 is an essential regulator ofheart function. Nature 417, 822-828
33. Chappel, M.C. et al. (1998) Metabolism of angiotensin (1-7) by angiotensin-converting enzyme. Hypertension 31, 362-367
34. Ferrario, C.M. et al. (1997) Counterregulatory actions of angiotensin (1-7). Hypertension 30, 535-541
35. Santos, R.A. et al. (2002) Evidence that angiotensin (1-7) is an endogenous ligand for the G-protein-coupled receptor Mas. Hypertension 1, 1
36. Handa, R.K. et al. (1996) Renal actions of angiotensin (1-7), in vivo and in vitro studies. Am. J. Physiol. 270, F141-F147
37. Paula, R.D. et al. (1995) Angiotensin (1-7) potentiates hypotensive effect of bradykinin in conscious rats. Hypertension 26, 1154-1159
38. Tallant, E.A. et al. (1999) Antiproliferative actions of angiotensin (1-7) in vascular smooth muscle. Hypertension 34, 950-957
39. 2 receptor in renal wrap hypertension model. Hypertension 33, 1237-1242
40. Tsutsumi, Y. et al. (1999) Angiotensin II type II receptor overexpression activates the vascular kinin system and causes vasodilation. J. Clin. Invest. 104, 925-935
41. 2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J. Clin. Invest. 100, 264-269
42. 1 receptor blockade. Hypertension 35, 1074-1077
43. Gross, V. et al. (2000) Inhibition of pressure-natriuresis in mice lacking the AT2 receptor. Kidney Int. 57, 191-202
44. Jin, X-H. et al. (2001) Renal interstitial guanosine cyclic 3′, 5′-monomonophophate induces natriuresis by a direct tubule mechanism. Hypertension 38, 309-316
45. Arima, S. et al. (1997) Possible role of P-450 metabolites of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused arteriole. J. Clin. Invest. 100, 2816-2823
46. 2 degradation is prevented by ligand occupation. Biochem. Biophys. Res. Commun. 243, 142-147
47. 1 receptor blockade. Hypertension 40, 516-520
48. 4 system in mediating natriuresis in the rat. Peptides 22, 935-944
49. Handa, R.K. et al. (2001) Autoradiographic analysis and regulation of angiotensin receptor subtypes AT (4), AT (1) and AT (1-7) in the kidney. Am. J. Physiol. Renal Physiol. 281, F936-F947
50. 4 receptor system in the rat kidney. Am. J. Physiol. 274, F290-F299
51. 4) receptor is the enzyme insulin-regulated aminopeptidase. J. Biol. Chem. 276, 48623-48626
52. 1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature 407, 94-98
53. 1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat. Med. 7, 1003-1008
54. 1 receptor antagonist. J. Biol. Chem. 276, 39721-39726
55. Price, D.A. et al. (1999) The paradox of the low renin state in diabetic nephropathy. J. Am. Soc. Nephrol. 10, 2382-2391
56. Anderson, S. et al. (1993) Renal renin-angiotensin system in diabetes. Functional, immunohistochemical and molecular biological correlations. Am. J. Physiol. 265, F477-F486
57. Zimpelman, J. et al. (2000) Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat. Kidney Int. 58, 2320-2330
58. Choi, K.C. et al. (1997) Alterations of intrarenal renin-angiotensin and nitric oxide systems in streptozotocin-induced diabetic rats. Kidney Int. Suppl. 60, S23-S27
59. Ahang, S-L. et al. (1999) Molecular mechanisms of glucose action on angiotensinogen gene expression in rat proximal tubular cells. Kidney Int. 55, 454-464
60. Hsieh, T-J. et al. (2002) High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubule cells. Endocrinology 143, 2975-2985
61. Mizuiri, S. et al. (1998) Renal ACE immunohistochemical localization in NIDDM patients with nephropathy. Am. J. Kidney Dis. 31, 301-307
62. Singh, R. et al. (1999) Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation. Diabetes 48, 2066-2073
63. Vallon, V. et al. (1995) Renal hemodynamic and plasma and kidney angiotensin II in established diabetes mellitus in rats. Effects of sodium and salt restriction. J. Am. Soc. Nephrol. 5, 1761-1767
64. Campbell, D.J. et al. (1999) Increased bradykinin and 'normal' angiotensin peptide levels in diabetic Sprague-dawley and transgenic (mRen-2) 27 rats. Kidney Int. 56, 211-221
65. Anderson, S. (1998) Physiologic actions and molecular expression of the renin-angiotensin system in the diabetic rat. Miner. Electrolyte Metab. 24, 406-411
66. Brown, L. et al. (1997) Tissue-specific changes in angiotensin II receptors in streptozotocin-diabetic rats. J. Endocrinol. 154, 355-362
67. 2 receptors. Am. J. Physiol. Renal Physiol. 280, F254-F265
68. Bonnet, F. et al. (2002) Renal expression of angiotensin receptors in long-term diabetes and the effects of angiotensin type 1 receptor blockade. J. Hypertens. 20, 1615-1624
69. Kelly, D.J. et al. (1998) A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mREN-2) 27 rat (TGR). Kidney Int. 54, 343-352
70. Kelly, D.J. et al. (2000) Effects of endothelin and angiotensin II receptor blockade on diabetes in the transgenic (mREN-2) 27 rat. Kidney Int. 57, 1882-1894
71. Wilkinson-Berka, J.L. et al. (2002) ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2) 27 rat. Diabetes 51, 3283-3289
72. Velloso, L.A. et al. (1996) Cross-talk between insulin and angiotensin signaling systems. Proc. Natl. Acad. Sci. U. S. A. 93, 12490-12495
73. Folli, F. et al. (1997) Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. J. Clin. Invest. 100, 2158-2169
74. Ogihara, T. et al. (2002) Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling. Hypertension 40, 872-879
75. Leehy, D.J. et al. (1995) Decreased degradative enzymes in mesangial cells cultured in high glucose medium. Diabetes 44, 929-935
76. Yamamoto, T. et al. (1993) Diabetic kidney disease is linked to elevated expression of transforming growth factor-β. Proc. Natl. Acad. Sci. U. S. A. 90, 1814-1818
77. Kagami, S. et al. (1994) Angiotensin II stimulated extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular cells. J. Clin. Invest. 93, 2431-2437
78. Sharma, K. et al. (1999) Captopril-induced reduction of serum levels of transforming growth factor-β1 correlates with long term renoprotection in insulin-dependent diabetic patients. Am. J. Kidney Dis. 34, 818-823
79. Miller, J.A. et al. (2000) Angiotensin II type 1 receptor gene polymorphism and the response to hyperglycemia in early type 1 diabetes. Diabetes 49, 1585-1589
80. Hollenberg, N.K. et al. (2003) Glomerular hemodynamics and the renin-angiotensin system in patients with type 1 diabetes mellitus. Kidney Int. 63, 172-178
81. Rocha, R. et al. (2000) Aldosterone: a mediator of myocardial necrosis and renal arteriopathy. Endocrinology 141, 3871-3878
82. Sato, A. et al. (2003) Effectiveness of aldosterone blockade in patients with diabetic nephropathy. Hypertension 41, 64-68